LC-MS/MS quantitation of ribavirin in serum and identification of endogenous isobaric interferences.

[1]  J. Hayashi,et al.  Ribavirin concentration in the later stages of 48 week pegylated interferon-alpha2b plus ribavirin therapy for chronic hepatitis C is useful for predicting virological response. , 2011, The Journal of antimicrobial chemotherapy.

[2]  G. Norkrans,et al.  Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection , 2011, Journal of viral hepatitis.

[3]  J. Drenth,et al.  Ribavirin Plasma Concentration Measurements in Patients With Hepatitis C: Early Ribavirin Concentrations Predict Steady-State Concentrations , 2011, Therapeutic drug monitoring.

[4]  William M. Lee,et al.  Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate. , 2010, Gastroenterology.

[5]  G. Duverlie,et al.  Ribavirin Monitoring in Chronic Hepatitis C Therapy: Anaemia versus Efficacy , 2010, Antiviral therapy.

[6]  P. Marquet,et al.  Feasibility of Ribavirin Therapeutic Drug Monitoring in Hepatitis C , 2009, Therapeutic drug monitoring.

[7]  V. Soriano,et al.  Usefulness of monitoring ribavirin plasma concentrations to improve treatment response in patients with chronic hepatitis C. , 2008, The Journal of antimicrobial chemotherapy.

[8]  P. Zhu,et al.  Rapid and sensitive HPLC-MS/MS method for pharmacokinetic assessment of ribavirin in healthy Chinese. , 2008, Biomedical chromatography : BMC.

[9]  C. Trépo,et al.  Prediction of Sustained Virological Response by Ribavirin Plasma Concentration at Week 4 of Therapy in Hepatitis C virus Genotype 1 Patients , 2008, Antiviral therapy.

[10]  G. di Perri,et al.  The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon. , 2008, The Journal of antimicrobial chemotherapy.

[11]  J. Dumortier,et al.  Plasma ribavirin concentrations during treatment of recurrent hepatitis C with peginterferon α‐2b and ribavirin combination after liver transplantation , 2006, Journal of viral hepatitis.

[12]  T. Annesley.  Ion suppression in mass spectrometry. , 2003, Clinical chemistry.